论文部分内容阅读
在近期出版的《风湿病学杂志》上发表的一项研究结果显示,抗环瓜氨酸蛋白抗体(anti-CCP)水平较低的类风湿性关节炎(RA)患者可能对抗肿瘤坏死因子(anti-TNF)单克隆抗体Infliximab的治疗反应不敏感。众所周知,含有瓜氨酸氨基酸残基的Anti-CCP可在许多类风湿性关节炎患者的
A study published in the recently published Journal of Rheumatology showed that patients with rheumatoid arthritis (RA) with low anti-cyclic citrullinated protein antibody (anti-CCP) may be resistant to anti-tumor necrosis factor anti-TNF) monoclonal antibody Infliximab treatment response insensitive. It is well-known that Anti-CCP containing citrulline amino acid residues can be found in many rheumatoid arthritis patients